glp-1-based treatments approved for weight loss 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ The FDA has approved the

This includes: [1] Methylphenidate (Concerta, Ritalin) Amphetamine (Dexedrine, Adderall) Non-stimulant medications used to treat ADHD are not controlled substances, as they do not share the same potential for abuse and dependence

They can help you navigate your feelings around all of your postpartum decisions, including this one

The majority of organizations (76 percent) provide GLP-1 drug coverage for diabetesthe original intended use for drugs including Ozempicfar outpacing the percentage of those providing coverage for weight loss, according to a new survey of 200 employers out from the International Foundation of Employee Benefit Plans (IFEBP)

The duration of elevated vitamin C blood levels is significantly longer with liposomal formulations [1]